Lung Neuroendocrine Tumor

general

A well-differentiated neuroendocrine neoplasm that arises from the lung. It is characterized by the presence of uniform polygonal cells with small or moderate amount of cytoplasm and inconspicuous nucleoli. The cells are usually arranged in organoid and trabecular patterns. It is classified as grade 1 (G1-typical carcinoid tumor) or grade 2 (G2-atypical carcinoid tumor) based on the number of mitotic figures and the absence or presence of necrosis. Grade 2 neuroendocrine tumors have a worse prog

67

Centers

244

Active Trials

$454M

Cancer Funding

Specific Cancer Types(6)

Top Centers for Lung Neuroendocrine Tumor(67)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
64.7
2
NCI Comprehensive
Active Research Program
64.7
3
NCI Comprehensive
Active Research Program
64.7
4
NCI Comprehensive
Active Research Program
64.7
564.7
6
NCI Comprehensive
Active Research Program
64.7
7
NCI Comprehensive
Active Research Program
64.7
8
NCI Comprehensive
Active Research Program
64.7
9
NCI Comprehensive
Active Research Program
64.7
10
NCI Comprehensive
Active Research Program
64.7
11
NCI Comprehensive
Active Research Program
64.7
12
NCI Comprehensive
Active Research Program
64.7
13
NCI Clinical
Active Research Program
64.7
14
NCI Comprehensive
Active Research Program
64.7
15
Active Research Program
64.7
16
NCI Clinical
Active Research Program
64.7
17
NCI Comprehensive
Active Research Program
64.7
18
Active Research Program
64.7
19
NCI Clinical
Active Research Program
64.7
20
NCI Comprehensive
Active Research Program
64.7
21
Active Research Program
64.7
22
Active Research Program
64.7
23
Active Research Program
64.7
24
Active Research Program
64.7
25
Active Research Program
64.7
26
NCI Comprehensive
Active Research Program
42.2
27
NCI Comprehensive
Active Research Program
42.2
28
NCI Comprehensive
Active Research Program
42.2
29
NCI Comprehensive
Active Research Program
42.2
30
NCI Comprehensive
Active Research Program
42.2
31
NCI Comprehensive
Active Research Program
42.2
32
NCI Comprehensive
Active Research Program
42.2
33
NCI Comprehensive
Active Research Program
42.2
34
NCI Comprehensive
Active Research Program
42.2
35
NCI Comprehensive
Active Research Program
42.2
36
NCI Comprehensive
Active Research Program
42.2
37
NCI Comprehensive
Active Research Program
42.2
38
NCI Comprehensive
Active Research Program
42.2
39
NCI Comprehensive
Active Research Program
42.2
40
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
42.2
41
NCI Comprehensive
Active Research Program
42.2
42
NCI Comprehensive
Active Research Program
42.2
43
NCI Comprehensive
Active Research Program
42.2
44
NCI Clinical
Active Research Program
42.2
45
NCI Comprehensive
Active Research Program
42.2
46
NCI Comprehensive
Active Research Program
42.2
47
Active Research Program
42.2
48
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
42.2
49
NCI Comprehensive
Active Research Program
42.2
50
NCI Clinical
Active Research Program
42.2
51
NCI Comprehensive
Active Research Program
42.2
52
NCI Comprehensive
Active Research Program
42.2
53
NCI Comprehensive
Active Research Program
42.2
54
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
42.2
55
Active Research Program
42.2
56
NCI Comprehensive
Active Research Program
42.2
5742.2
58
Active Research Program
42.2
59
NCI Basic_laboratory
Active Research Program
42.2
60
Active Research Program
42.2
61
Active Research Program
42.2
62
Active Research Program
42.2
63
Active Research Program
42.2
64
Active Research Program
42.2
65
Active Research Program
42.2
66
Active Research Program
42.2
67
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →